Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial Assessing the Impact on Instrumental and Daily Living Autonomy of a Chemotherapy With Biweekly Docetaxel in the Treatment of Metastatic Breast Cancer in Patients Over 70

NCT00104624 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT00104624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00104624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial Assessing the Impact on Instrumental and Daily Living Autonomy of a Chemotherapy With Biweekly Docetaxel in the Treatment of Metastatic Breast Cancer in Patients Over 70
Lead sponsor
UNICANCER
Phase
Phase 2
Overall status
Terminated
Start date
May 31, 2005
Completion date
July 31, 2008
Enrollment
53 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer